These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Replacement of dehydroepiandrosterone enhances T-lymphocyte insulin binding in postmenopausal women. Casson PR; Faquin LC; Stentz FB; Straughn AB; Andersen RN; Abraham GE; Buster JE Fertil Steril; 1995 May; 63(5):1027-31. PubMed ID: 7720912 [TBL] [Abstract][Full Text] [Related]
10. Long-term low-dose dehydroepiandrosterone oral supplementation in early and late postmenopausal women modulates endocrine parameters and synthesis of neuroactive steroids. Genazzani AD; Stomati M; Bernardi F; Pieri M; Rovati L; Genazzani AR Fertil Steril; 2003 Dec; 80(6):1495-501. PubMed ID: 14667889 [TBL] [Abstract][Full Text] [Related]
11. Dehydroepiandrosterone treatment in the aging male--what should the urologist know? Saad F; Hoesl CE; Oettel M; Fauteck JD; Römmler A Eur Urol; 2005 Nov; 48(5):724-33; discussion 733. PubMed ID: 16137821 [TBL] [Abstract][Full Text] [Related]
12. Oral dehydroepiandrosterone supplementation modulates spontaneous and growth hormone-releasing hormone-induced growth hormone and insulin-like growth factor-1 secretion in early and late postmenopausal women. Genazzani AD; Stomati M; Strucchi C; Puccetti S; Luisi S; Genazzani AR Fertil Steril; 2001 Aug; 76(2):241-8. PubMed ID: 11476767 [TBL] [Abstract][Full Text] [Related]
13. Wide distribution of the serum dehydroepiandrosterone and sex steroid levels in postmenopausal women: role of the ovary? Labrie F; Martel C; Balser J Menopause; 2011 Jan; 18(1):30-43. PubMed ID: 20683211 [TBL] [Abstract][Full Text] [Related]
14. Lack of effect of intravaginal dehydroepiandrosterone (DHEA, prasterone) on the endometrium in postmenopausal women. Portman DJ; Labrie F; Archer DF; Bouchard C; Cusan L; Girard G; Ayotte N; Koltun W; Blouin F; Young D; Wade A; Martel C; Dubé R; Menopause; 2015 Dec; 22(12):1289-95. PubMed ID: 25968836 [TBL] [Abstract][Full Text] [Related]
15. Treatment of systemic lupus erythematosus with dehydroepiandrosterone: 50 patients treated up to 12 months. van Vollenhoven RF; Morabito LM; Engleman EG; McGuire JL J Rheumatol; 1998 Feb; 25(2):285-9. PubMed ID: 9489820 [TBL] [Abstract][Full Text] [Related]
16. [The putative role and use of DHEA and its association with the hormone replacement therapy]. Prati A; Santagni S; Rattighieri E; Campedelli A; Ricchieri F; Chierchia E; Despini G; Genazzani AR; Genazzani AD Minerva Ginecol; 2014 Jun; 66(3):313-24. PubMed ID: 24971788 [TBL] [Abstract][Full Text] [Related]
18. Serum dehydroepiandrosterone (DHEA) and DHEA sulfate are negatively correlated with serum interleukin-6 (IL-6), and DHEA inhibits IL-6 secretion from mononuclear cells in man in vitro: possible link between endocrinosenescence and immunosenescence. Straub RH; Konecna L; Hrach S; Rothe G; Kreutz M; Schölmerich J; Falk W; Lang B J Clin Endocrinol Metab; 1998 Jun; 83(6):2012-7. PubMed ID: 9626133 [TBL] [Abstract][Full Text] [Related]
19. Effects of aging on adrenal function in the human: responsiveness and sensitivity of adrenal androgens and cortisol to adrenocorticotropin in premenopausal and postmenopausal women. Parker CR; Slayden SM; Azziz R; Crabbe SL; Hines GA; Boots LR; Bae S J Clin Endocrinol Metab; 2000 Jan; 85(1):48-54. PubMed ID: 10634362 [TBL] [Abstract][Full Text] [Related]
20. Dehydroepiandrosterone supplementation and bone turnover in middle-aged to elderly men. Kahn AJ; Halloran B; Wolkowitz O; Brizendine L J Clin Endocrinol Metab; 2002 Apr; 87(4):1544-9. PubMed ID: 11932279 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]